Vycor Launches New Extension Arm

Vycor Medical Inc. officials announce that it has finalized the production and the U.S. commercial launch of an extension arm for its existing ViewSite Brain Access System (VBAS) medical device product range. It is currently anticipated that the extension arm will be available in Europe by the end of April.

VBAS is a suite of clear cylindrical disposable devices, which provide neurosurgeons a stable, minimally invasive working channel to access targeted sites within the brain, such as tumors. The blade retractor has been the standard of care device for brain access and retraction for more than 50 years. VBAS is now approved in over 100 hospitals in the U.S. and the number continues to grow. To date, more than 4,000 surgeries have been performed utilizing VBAS.

As part of Vycor's strategy to drive growth in the use of its existing VBAS product range, the company is developing ancillary products that would facilitate its use. To this end, the company has launched in the U.S. the new extension arm (a non-disposable accessory to the existing VBAS product) which connects to the protruding tab of the VBAS working channel. This attachment arm gives the surgeon more space to operate as well as the ability to have the VBAS flush with the corticotomy. It is compatible with most arms that come off the halo and will provide additional functionality with most image-guided systems by providing a connection point for the tracker of the IGS. This device is a re-usable ancillary product that will be sold separately to hospitals.

"We are very excited by the availability of the new VBAS Extension Arm which we believe will help drive our VBAS sales and help it become the de-facto new Standard of Care when it comes to brain access and retraction. Prior to the introduction of any new complementary VBAS devices, our existing VBAS product range already address approximately 200,000 annual applicable procedures in the U.S. alone, and we anticipate this new extension arm will further help drive the product's adoption," states David Cantor, president, Vycor.

Vycor Medical Inc. operates two business units: Vycor Medical and NovaVision, both of which adopt a minimally or non-invasive approach. Both technologies have exceptional sales growth potential, address large potential markets, have the requisite regulatory approvals, and are commercialized and generating revenue. 

For an overview of Vycor Medical's VBAS click here.

For an overview of NovaVision click here.